Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway (Q37062514)
Jump to navigation
Jump to search
scientific article published on 02 April 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway |
scientific article published on 02 April 2016 |
Statements
1 reference
Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway (English)
1 reference
Zhifeng Gu
1 reference
Wei Tan
1 reference
Juan Ji
1 reference
Guijian Feng
1 reference
Yan Meng
1 reference
Zhanyun Da
1 reference
Genkai Guo
1 reference
Yunfei Xia
1 reference
Xinhang Zhu
1 reference
Guixiu Shi
1 reference
Chun Cheng
1 reference
2 April 2016
1 reference
1 reference
1102-1114
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference